ARCHIVES

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

This article is from The Cancer Letter archive.

Vol. 35 No. 38 | October 16, 2009

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

FDA Approves Implant For Breast Reconstruction

July 26, 2013

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978